ADVERTISEMENT
Emily Shugerman is a senior reporter for the Daily Beast. She previously worked as a US correspondent for The Independent. Send her tips: emily.shugerman@thedailybeast.com or tips@thedailybeast.com.
ADVERTISEMENT

Surrogate ‘Scammer’ Goes Missing: Parents, Babies in Limbo
FAMILIES’ AGONYA Texas company promised to keep families’ money safe during the delicate process of gestational surrogacy. Then its founder—and all the clients’ money—vanished.

The Hottest Celeb in the Hamptons This Summer Is a Flamingo
PRETTY IN PINKA flamingo has taken up residence in a pond in the ritzy beach town, and is causing a stir.

‘Tradwives’: All You Wanted to Know, but Were Afraid to Ask
PERFECTLY WEIRDLilly Gaddis’ racist video spurred interest in a popular subset of influencers who claim being a homemaker is liberating.

‘Anti-Woke’ Water Makes a Splash at Conservative Conference
DRINK UP“It’s not just refreshing, it’s rebellious, and it’s unapologetic to drink this in public.”

MTG Vows to ‘Lock Up’ Fauci for ‘Crimes Against Humanity’
CLOWN-AT-LARGE MARGEGreene lashed out at Fauci and Democratic politicians at a conservative conference while audience members chanted “Lock him up!”

Vandals Break Pride Flags at Stonewall Monument
‘DISGUSTING’Police said 160 flags were broken at the historic monument in New York City during Pride month.

‘Little Marco’ Makes Surprise Appearance at Trump’s Birthday
MAKE A WISHThe event marked Rubio’s first appearance on the campaign trail since rumors started swirling that he might get the VP nod.

Bill Maher Begs for the Return of the ‘Trad Dad’
TIME WARPThe late-night host argued for the return of tough-love dads—lest teens start turning to influencers like Andrew Tate for male influence.

Fate of Marilyn Monroe’s Final Home Put on Hold
FAMOUS HOUSESThe Los Angeles City Council delayed a vote this week on whether to designate the home a national monument, which would block its neighbors from demolishing it.

The Fight Over the Abortion Pill Is Only Just Beginning
BATTLE LINESThe Supreme Court may have preserved access for now, but challenges to the medication are mounting.
ADVERTISEMENT